Copyright
©The Author(s) 2020.
World J Gastroenterol. May 21, 2020; 26(19): 2374-2387
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2374
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2374
Figure 2 Impact of post-transplant dyslipidemia on survival.
A: Comparison of overall survival between post-transplant dyslipidemia and non-post-transplant dyslipidemia groups in all patients; B: Comparison of overall survival between post-transplant dyslipidemia and non-post-transplant dyslipidemia groups in hepatocellular carcinoma patients; C: Comparison of tumor-free survival between post-transplant dyslipidemia and non-post-transplant dyslipidemia groups in hepatocellular carcinoma patients. PTDL: Post-transplant dyslipidemia; LT: Liver transplantation; HCC: Hepatocellular carcinoma.
- Citation: Huang HT, Zhang XY, Zhang C, Ling Q, Zheng SS. Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile. World J Gastroenterol 2020; 26(19): 2374-2387
- URL: https://www.wjgnet.com/1007-9327/full/v26/i19/2374.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i19.2374